Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01197898 · ClinicalTrials.gov registry record · Phase 4

Wound Edge Changes Following Treatment With Santyl

A Phase 4 study, sponsored by Healthpoint.

Completed
Registry status
Phase 4
Development phase
10
Enrollment target

NCT01197898: Completed Phase 4 study, sponsored by Healthpoint.

NCT01197898 is a Phase 4 study that has completed, run by Healthpoint. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01197898, a Phase 4 study, has completed, sponsored by Healthpoint.

COMPLETED
Registry status
Phase 4
Development phase
10 participants
Enrollment target

Study Summary

The goal of this study is to evaluate changes in the healing tissue of diabetic foot wounds following 14 days of treatment with Santyl or its vehicle base.

Primary Outcome

The results were found to be inconclusive due to the small number of biopsy specimens of sufficient quality for analysis. Four of the 10 subjects enrolled were not evaluable due to poor biopsy quality.

Interventions

  • OTHER Placebo Comparator
  • BIOLOGICAL Collagenase Santyl Ointment

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2010-12
Est. Completion 2012-10
Phase Phase 4
Healthpoint

25 total trials

What the finished NCT01197898 record still lists

NCT01197898 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.

NCT01197898 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01197898 about?

NCT01197898 is a clinical study titled "Wound Edge Changes Following Treatment With Santyl". The goal of this study is to evaluate changes in the healing tissue of diabetic foot wounds following 14 days of treatment with Santyl or its vehicle base.

What is the current status of trial NCT01197898?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2010-12. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01197898?

The interventions under investigation include: Placebo Comparator (OTHER), Collagenase Santyl Ointment (BIOLOGICAL).

Who is sponsoring clinical trial NCT01197898?

This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01197898's enrollment target sits among peer trials

10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01197898, the US trial registry maintained by the National Library of Medicine. NCT01197898 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.